Nanomedicine: Perspective and promises with ligand-directed molecular imaging

Dipanjan Pan, Gregory M. Lanza, Samuel A. Wickline, Shelton D. Caruthers

Research output: Contribution to journalArticlepeer-review

Abstract

Molecular imaging and targeted drug delivery play an important role toward personalized medicine, which is the future of patient management. Of late, nanoparticle-based molecular imaging has emerged as an interdisciplinary area, which shows promises to understand the components, processes, dynamics and therapies of a disease at a molecular level. The unprecedented potential of nanoplatforms for early detection, diagnosis and personalized treatment of diseases, have found application in every biomedical imaging modality. Biological and biophysical barriers are overcome by the integration of targeting ligands, imaging agents and therapeutics into the nanoplatform which allow for theranostic applications. In this article, we have discussed the opportunities and potential of targeted molecular imaging with various modalities putting a particular emphasis on perfluorocarbon nanoemulsion-based platform technology.

Original languageEnglish (US)
Pages (from-to)274-285
Number of pages12
JournalEuropean Journal of Radiology
Volume70
Issue number2
DOIs
StatePublished - May 1 2009
Externally publishedYes

Keywords

  • Computed Tomography
  • Contrast agents
  • Drug delivery
  • Magnetic Resonance Imaging
  • Nanotechnology
  • Ultrasound

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Nanomedicine: Perspective and promises with ligand-directed molecular imaging'. Together they form a unique fingerprint.

Cite this